Please Wait.....
Report
Europe Stem Cell Assay Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Europe Stem Cell Assay Market Report and Forecast 2024-2032
Europe Stem Cell Assay Market Outlook
The global stem cell assay market size was valued at USD 6.4 billion in 2023, with Europe holding a significant market share. The market is driven by the rising technological innovations in the field of stem cell assays. It is expected to grow at a CAGR of 20.10% during the forecast period of 2024-2032, with the values likely to attain USD 19.4 billion by 2032.
Key Takeaways
- On January 1, 2023, it was estimated that more than one-fifth of the population of the European Union was aged 65 years and above. The rising aging population fuels the need for novel therapeutic solutions, which directly impacts the market demand.
- One of the major Europe stem cell assay market trends is the rising technological advancements in the field of stem cell assays such as automation and high-throughput screening technologies which are likely to boost efficiency and improve the accuracy of stem cell research and testing.
- The rising impetus for stem cell research coupled with the presence of a robust research infrastructure in the region is likely to elevate market value. For instance, in June 2023, the University of Cambridge initiated a stem cell-based human embryo model project in the United Kingdom.
Europe Stem Cell Assay Market Analysis
Stem cell assays are laboratory tests that are used to evaluate the behavior or function of stem cells. In Europe, they are widely utilized in clinical and research settings to obtain data on stem cell differentiation, viability, and proliferation, among others. These assays are increasingly employed in cancer research and regenerative medicine to find potential treatments for various diseases. The rising prevalence of chronic conditions including diabetes, cardiovascular diseases, and neurodegenerative disorders is expected to drive the Europe stem cell assay market growth in the coming years.
The market is significantly impacted by the rising aging population. On January 1, 2023, it was estimated that more than one-fifth of the population of the European Union was aged 65 years and above, with the median age reaching 44.5 yea rs. This growing size of the aging population in Europe reflects the need for novel therapeutic solutions, including those developed through stem cell research, which is likely to drive the market demand in the forecast period.
The rising integration of advanced and automated cell counting methods to assess stem cell viability is leading to a reduction in analyst-dependent variability and the analytical time in research labs and manufacturing facilities . This is anticipated to propel the Europe stem cell assay market demand. Additionally, these rising technological advancements in the field of stem cell assays such as high-throughput screening technologies are likely to boost efficiency and improve the accuracy of stem cell research and testing, thereby supporting market growth.
In Europe, the rising emphasis for stem cell research coupled with the presence of an established research infrastructure in the region is accelerating market growth. For instance, in June 2023, the University of Cambridge launched a project involving stem cell-based human embryo models in the United Kingdom. Such stem cell-based research activities are likely to augment the demand for various types of stem cell assays to understand stem cell biology and consequently develop stem cell therapies, ultimately elevating the market value.
Europe Stem Cell Assay Market Segmentation??
Market Breakup by Cell Type
- Adult Stem Cells
- Human Embryonic Stem Cells
- Pluripotent
Market Breakup by Type
- Viability/Cytotoxicity Assays
- Isolation and Purification Assays
- Cell Identification Assays
- Proliferation Assays
- Differentiation Assays
- Function Assays
- Apoptosis Assays
- Others
Market Breakup by Product and Service
- Flow Cytometers
- Cell Imaging and Analysis Systems
- Microelectrode Arrays
- Automated Cell Counters
- Kits
Market Breakup by Treatment
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
- Syngeneic Stem Cell Therapy
Market Breakup by Application
- Regenerative Medicine and Therapy Development
- Drug Discovery and Development
- Clinical Research
- Others
Market Breakup by End User
- Biopharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Market Breakup by Countries
- United Kingdom
- Germany
- France
- Italy
- Others
Europe Stem Cell Assay Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- PerkinElmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Europe stem cell assay market forecast outlook for 2024-2032?
The Europe stem cell assay market is expected to be driven by the rising demand for the global stem cell assay market, which is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032 and is likely to reach a market value of USD 19.4 billion by 2032.
- What are the major factors aiding the Europe stem cell assay market demand?
The rising application of stem cell assays in cancer research and regenerative medicine to find potential treatments for various chronic conditions is fuelling the demand for the market.
- What are the major Europe stem cell assay market trends?
One of the significant trends in the market is the increased stem cell-based research activities which are likely to augment the demand for various types of stem cell assays. For instance, in June 2023, the University of Cambridge launched a project involving stem cell-based human embryo models in the United Kingdom.
- What is the market segmentation based on the cell type?
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
- What is the market breakup by type?
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
- What is the market segmentation based on product and services?
Based on the product and services, the market is segmented into flow cytometers, cell imaging and analysis systems, microelectrode arrays, automated cell counters, and kits.
- What are the various treatments available in the market?
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
- What are the applications of stem cell assay?
Major applications include regenerative medicine and therapy development, drug discovery and development, as well as clinical research, among others.
- What are the major end users of stem cell assay?
End users of the market are biopharmaceutical and biotechnology companies, along with academic and research institutes, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
- Who are the key players involved in the Europe stem cell assay market?
The key players in the market are Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Meta description
Europe stem cell assay market is poised for growth, driven by the expansion of the global market, which was valued at USD 6.4 billion in 2023 and is projected to grow at a CAGR of 13.18% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Stem Cell Assay Market Overview
3.1 Europe Stem Cell Assay Market Historical Value (2017-2023)
3.2 Europe Stem Cell Assay Market Forecast Value (2024-2032)
4 Europe Stem Cell Assay Market Landscape*
4.1 Europe Stem Cell Assay: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Stem Cell Assay: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Treatment
5 Europe Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Stem Cell Assay Market Segmentation (2017-2032)
6.1 Europe Stem Cell Assay Market (2017-2032) by Cell Type
6.1.1 Market Overview
6.1.2 Adult Stem Cells
6.1.3 Human Embryonic Stem Cells
6.1.4 Pluripotent
6.2 Europe Stem Cell Assay Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 Viability /Cytotoxicity Assays
6.2.3 Isolation & Purification Assays
6.2.4 Cell Identification Assays
6.2.5 Proliferation Assays
6.2.6 Differentiation Assays
6.2.7 Function Assays
6.2.8 Apoptosis Assays
6.2.9 Others
6.3 Europe Stem Cell Assay Market (2017-2032) by Product & Service
6.3.1 Market Overview
6.3.2 Flow Cytometers
6.3.3 Cell Imaging & Analysis Systems
6.3.4 Microelectrode Arrays
6.3.5 Automated Cell Counters
6.3.6 Kits
6.4 Europe Stem Cell Assay Market (2017-2032) by Treatment
6.4.1 Market Overview
6.4.2 Allogeneic Stem Cell Therapy
6.4.3 Autologic Stem Cell Therapy
6.4.4 Syngeneic Stem Cell Therapy
6.5 Europe Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Regenerative Medicine &Therapy Development
6.5.3 Drug Discovery & Development
6.5.4 Clinical Research
6.5.5 Others
6.6 Europe Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biopharmaceutical & Biotechnology Companies
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 Europe Stem Cell Assay Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United Kingdom
6.7.3 Germany
6.7.4 France
6.7.5 Italy
6.7.6 Others
7 United Kingdom of Stem Cell Assay Market (2017-2032)
7.1 United Kingdom Stem Cell Assay Market (2017-2032) by Cell Type
7.1.1 Market Overview
7.1.2 Adult Stem Cells
7.1.3 Human Embryonic Stem Cells
7.1.4 Pluripotent
7.2 United Kingdom Stem Cell Assay Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 Viability /Cytotoxicity Assays
7.2.3 Isolation & Purification Assays
7.2.4 Cell Identification Assays
7.2.5 Proliferation Assays
7.2.6 Differentiation Assays
7.2.7 Function Assays
7.2.8 Apoptosis Assays
7.2.9 Others
7.3 United Kingdom Stem Cell Assay Market (2017-2032) by Product & Service
7.3.1 Market Overview
7.3.2 Flow Cytometers
7.3.3 Cell Imaging & Analysis Systems
7.3.4 Microelectrode Arrays
7.3.5 Automated Cell Counters
7.3.6 Kits
7.4 United Kingdom Stem Cell Assay Market (2017-2032) by Treatment
7.4.1 Market Overview
7.4.2 Allogeneic Stem Cell Therapy
7.4.3 Autologic Stem Cell Therapy
7.4.4 Syngeneic Stem Cell Therapy
7.5 United Kingdom America Stem Cell Assay Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Biopharmaceutical & Biotechnology Companies
7.5.3 Academic & Research Institutes
7.5.4 Others
7.6 United Kingdom Stem Cell Assay Market (2017-2032) by Application
7.6.1 Market Overview
7.6.2 Regenerative Medicine &Therapy Development
7.6.3 Drug Discovery & Development
7.6.4 Clinical Research
7.6.5 Others
8 Germany Stem Cell Assay Market (2017-2032)
8.1 Germany Stem Cell Assay Market (2017-2032) by Cell Type
8.1.1 Market Overview
8.1.2 Adult Stem Cells
8.1.3 Human Embryonic Stem Cells
8.1.4 Pluripotent
8.2 Germany Stem Cell Assay Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 Viability /Cytotoxicity Assays
8.2.3 Isolation & Purification Assays
8.2.4 Cell Identification Assays
8.2.5 Proliferation Assays
8.2.6 Differentiation Assays
8.2.7 Function Assays
8.2.8 Apoptosis Assays
8.2.9 Others
8.3 Germany Stem Cell Assay Market (2017-2032) by Product & Service
8.3.1 Market Overview
8.3.2 Flow Cytometers
8.3.3 Cell Imaging & Analysis Systems
8.3.4 Microelectrode Arrays
8.3.5 Automated Cell Counters
8.3.6 Kits
8.4 Germany Stem Cell Assay Market (2017-2032) by Treatment
8.4.1 Market Overview
8.4.2 Allogeneic Stem Cell Therapy
8.4.3 Autologic Stem Cell Therapy
8.4.4 Syngeneic Stem Cell Therapy
8.5 Germany Stem Cell Assay Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Biopharmaceutical & Biotechnology Companies
8.5.3 Academic & Research Institutes
8.5.4 Others
8.6 Germany Stem Cell Assay Market (2017-2032) by Application
8.6.1 Market Overview
8.6.2 Regenerative Medicine &Therapy Development
8.6.3 Drug Discovery & Development
8.6.4 Clinical Research
9 France Stem Cell Assay Market (2017-2032)
9.1 France Stem Cell Assay Market (2017-2032) by Cell Type
9.1.1 Market Overview
9.1.2 Adult Stem Cells
9.1.3 Human Embryonic Stem Cells
9.1.4 Pluripotent
9.2 France Stem Cell Assay Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 Viability /Cytotoxicity Assays
9.2.3 Isolation & Purification Assays
9.2.4 Cell Identification Assays
9.2.5 Proliferation Assays
9.2.6 Differentiation Assays
9.2.7 Function Assays
9.2.8 Apoptosis Assays
9.2.9 Others
9.3 France Stem Cell Assay Market (2017-2032) by Product & Service
9.3.1 Market Overview
9.3.2 Flow Cytometers
9.3.3 Cell Imaging & Analysis Systems
9.3.4 Microelectrode Arrays
9.3.5 Automated Cell Counters
9.3.6 Kits
9.4 France Stem Cell Assay Market (2017-2032) by Treatment
9.4.1 Market Overview
9.4.2 Allogeneic Stem Cell Therapy
9.4.3 Autologic Stem Cell Therapy
9.4.4 Syngeneic Stem Cell Therapy
9.5 France Stem Cell Assay Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Biopharmaceutical & Biotechnology Companies
9.5.3 Academic & Research Institutes
9.5.4 Others
9.6 France Stem Cell Assay Market (2017-2032) by Application
9.6.1 Market Overview
9.6.2 Regenerative Medicine &Therapy Development
9.6.3 Drug Discovery & Development
9.6.4 Clinical Research
9.6.5 Others
10 Italy Stem Cell Assay Market (2017-2032)
10.1 Italy Stem Cell Assay Market (2017-2032) by Cell Type
10.1.1 Market Overview
10.1.2 Adult Stem Cells
10.1.3 Human Embryonic Stem Cells
10.1.4 Pluripotent
10.2 Italy Stem Cell Assay Market (2017-2032) by Type
10.2.1 Market Overview
10.2.2 Viability /Cytotoxicity Assays
10.2.3 Isolation & Purification Assays
10.2.4 Cell Identification Assays
10.2.5 Proliferation Assays
10.2.6 Differentiation Assays
10.2.7 Function Assays
10.2.8 Apoptosis Assays
10.2.9 Others
10.3 Italy Stem Cell Assay Market (2017-2032) by Product & Service
10.3.1 Market Overview
10.3.2 Flow Cytometers
10.3.3 Cell Imaging & Analysis Systems
10.3.4 Microelectrode Arrays
10.3.5 Automated Cell Counters
10.3.6 Kits
10.4 Italy Stem Cell Assay Market (2017-2032) by Treatment
10.4.1 Market Overview
10.4.2 Allogeneic Stem Cell Therapy
10.4.3 Autologic Stem Cell Therapy
10.4.4 Syngeneic Stem Cell Therapy
10.5 Italy Stem Cell Assay Market (2017-2032) by End User
10.5.1 Market Overview
10.5.2 Biopharmaceutical & Biotechnology Companies
10.5.3 Academic & Research Institutes
10.5.4 Others
10.6 Italy Stem Cell Assay Market (2017-2032) by Application
10.6.1 Market Overview
10.6.2 Regenerative Medicine &Therapy Development
10.6.3 Drug Discovery & Development
10.6.4 Clinical Research
10.6.5 Others
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Thermo Fisher Scientific
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 PerkinElmer
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Stemcell Technologies
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Merck
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Bio-Rad Laboratories
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Agilent Technologies
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Promega
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Bio-Techne
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Cell Biolabs
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Europe Stem Cell Assay Market - Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security